-
由國家新藥篩選中心主辦的 2016年皇后鎮(zhèn)分子生物學(xué)(上海)會(huì)議于2016-03-17在中國金融信息中心舉辦。
首頁>演講嘉賓> Jack Flanagan更新時(shí)間:2016-03-17
Jack Flanagan, Senior Research Fellow of University of Auckland. Jack Flanagan obtained his BSc(Hons) in Biochemistry and Molecular Genetics at Victoria University of Wellington, New Zealand, and was awarded a PhD scholarship to study at the John Curtin School of Medical Research, Australian National University, Australia where he investigated structure function relationships for the glutathione transferase class of detoxication enzyme in the laboratory of Prof Philip Board. After a postdoctoral position researching structure function relationships in the major drug metabolising cytochromes P450 under Prof Roland Wolf at the Biomedical Research Centre, University of Dundee, United Kingdom, he took up a Howard Florey Centenary Fellowship at the Institute for Molecular Biosciences, University of Queensland, Australia looking at inhibitor discovery for the human hematopoietic prostaglandin D2 synthase enzyme. Currently a Senior Research Fellow at the Auckland Cancer Society Research Centre, Jack is involved in integrating molecular modelling and virtual screening methods of inhibitor discovery into a number of current medicinal chemistry projects. He is also an Associate Investigator in the Maurice Wilkins Centre for Molecular Biodiscovery.
Jack Flanagan出席會(huì)議日程
由國家新藥篩選中心主辦的 2016年皇后鎮(zhèn)分子生物學(xué)(上海)會(huì)議于2016-03-17在中國金融信息中心舉辦。